← FDA DRUG APPROVALS

FDA ANDA · ANDA203521

TRANEXAMIC ACID

Sponsor: AVET LIFESCIENCES

APPLICATION
ANDA203521
TYPE
ANDA
ORIGINAL APPROVAL
2014-08-12
LATEST ACTION
2023-09-12
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

TRANEXAMIC ACIDPrescription
TRANEXAMIC ACID 100MG/ML · INJECTABLE · INJECTION

Approval history

2023-09-12Labeling · Supplement 15 · standardAP
2020-08-11Labeling · Supplement 13 · standardAP
2019-06-28Labeling · Supplement 10 · standardAP
2014-08-12UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →